Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Chase Coleman’s Top Stock Picks $AAPL $GOOG $FTR $V $MA $PCLN

TIGER GLOBAL MANAGEMENT LLCCharles Payson Coleman III, “Chase,” is a Tiger Cub who got his bearings at Julian Robertson’s Tiger Management. At 36, he is one of the younger billionaire hedge fund managers and runs Tiger Global, a long/short equity fund with ~$6 billion in AUM, which is co-managed by Feroz Dewan. Coleman’s fund was seeded with $25 million from Robertson in 2000. At such a young age, you might ask how Coleman got into Robertson’s good graces in the first place. Well, it turns out that Coleman grew up with Robertson’s son Spencer. That being said, Coleman has been very successful in his own right. Last year, Tiger Global was the top performing hedge fund, returning 45%. Tiger Global tends to be weighted heavily in the technology sector, no surprise since Coleman was a tech analyst at Tiger Management for three years. And with the launch of a private equity arm in January 2011, the firm has invested in the likes of Zynga, Facebook, and Linkedin. A fellow hedge-fund executive notes that Coleman “invests in these things when they’re already at a couple hundred million in revenue. He’s not a VC guy, but he helps create valuations of these companies at the pre-IPO stage.”

As a descendant of Peter Stuyvesant, the last Dutch Director-General of the colony of New Netherland which eventually became New York as we know it today, Coleman is of “old money.”

Read the rest of the article here.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!